Meniere's disease: prevalence of contralateral ear involvement
- PMID: 16639274
- DOI: 10.1097/00129492-200604000-00011
Meniere's disease: prevalence of contralateral ear involvement
Abstract
Objective: Determine the prevalence and time interval for conversion from unilateral to bilateral involvement in Meniere's disease and cochlear hydrops.
Study design and setting: Retrospective chart review in a tertiary otologic referral center.
Patients: 232 patients diagnosed with Meniere's Disease (n=186) or cochlear hydrops (n=46) between 1959 and 2001, who visited the clinic over a five-year period between 1997-2001 and have at least 2 audiograms more than 12 months apart.
Main outcome measures: Prevalence of cochlear hydrops relative to Meniere's Disease, rate of progression from unilateral to bilateral involvement; interval between unilateral onset of symptoms and bilateral involvement; and rate of progression from cochlear hydrops to Meniere's disease.
Results: Initial diagnosis was Meniere's disease in 71% and cochlear hydrops in 29% of all 950 hydropic patients presenting between 1997 and 2001. In the study sample, Meniere's disease was bilateral at presentation in 11%; an additional 12% (14% of unilaterals) became bilateral during the follow-up period. At presentation, 6.5% of cochlear hydrops patients were bilateral, with another 26% becoming bilateral. Conversion from cochlear hydrops to Meniere's disease occurred in 33% and some of these are included among the bilateral. The average time interval for conversion from unilateral to bilateral Meniere's was 7.6 years (SD=7.0 years).
Conclusion: Most otologists are aware of the potential for contralateral ear involvement and conversion from cochlear hydrops to Meniere's disease after diagnosis. These changes are significant, require long-term follow-up for detection, and may necessitate further treatment. Patients should be counseled regarding this potential when interventions are considered, especially with respect to ablative treatments.
Similar articles
-
Cochlear implantation in patients with bilateral Ménière's syndrome.Otol Neurotol. 2003 May;24(3):397-403. doi: 10.1097/00129492-200305000-00009. Otol Neurotol. 2003. PMID: 12806291
-
Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?Otol Neurotol. 2005 Jan;26(1):74-81. doi: 10.1097/00129492-200501000-00013. Otol Neurotol. 2005. PMID: 15699723
-
Comparative analysis of classic and delayed Ménière's disease: clinical characteristics and endolymphatic hydrops manifestations in an Asian cohort.Eur Arch Otorhinolaryngol. 2025 Mar;282(3):1231-1236. doi: 10.1007/s00405-024-09025-w. Epub 2024 Oct 15. Eur Arch Otorhinolaryngol. 2025. PMID: 39404881
-
What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.J Neurol. 2016 Apr;263 Suppl 1:S71-81. doi: 10.1007/s00415-015-7930-1. Epub 2016 Apr 15. J Neurol. 2016. PMID: 27083887 Free PMC article. Review.
-
History of Meniere's disease and its clinical presentation.Otolaryngol Clin North Am. 2002 Jun;35(3):565-80. doi: 10.1016/s0030-6665(02)00017-8. Otolaryngol Clin North Am. 2002. PMID: 12486840 Review.
Cited by
-
Long-term efficacy of dexamethasone treatment via tympanic antrum catheterization for intractable Meniere's disease.Front Neurol. 2022 Dec 2;13:1056724. doi: 10.3389/fneur.2022.1056724. eCollection 2022. Front Neurol. 2022. PMID: 36530627 Free PMC article. Review.
-
Visualization and clinical relevance of the endolymphatic duct and sac in Ménière's disease.Front Neurol. 2023 Aug 31;14:1239422. doi: 10.3389/fneur.2023.1239422. eCollection 2023. Front Neurol. 2023. PMID: 37719762 Free PMC article.
-
Hydropic Ear Disease: Correlation Between Audiovestibular Symptoms, Endolymphatic Hydrops and Blood-Labyrinth Barrier Impairment.Front Surg. 2021 Nov 4;8:758947. doi: 10.3389/fsurg.2021.758947. eCollection 2021. Front Surg. 2021. PMID: 34805261 Free PMC article.
-
Long-Term Risk of Progression From Unilateral to Bilateral Méniere's Disease: A Systematic Review and Meta-Analysis.Otol Neurotol. 2025 Jun 1;46(5):485-493. doi: 10.1097/MAO.0000000000004491. Epub 2025 Apr 11. Otol Neurotol. 2025. PMID: 40210232 Free PMC article.
-
A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere's disease.Hum Mol Genet. 2016 Aug 15;25(16):3407-3415. doi: 10.1093/hmg/ddw183. Epub 2016 Jun 21. Hum Mol Genet. 2016. PMID: 27329761 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical